Skip to main
DBD
DBD logo

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf is experiencing an anticipated increase in Retail sales in Europe, projected to grow both sequentially and year-over-year in the upcoming quarters. The company is showing a strong financial performance with sustainably positive free cash flow (FCF), expected to nearly double by 2025, reaching an estimated $205 million. Additionally, Diebold Nixdorf's balance sheet and liquidity are reported to be in their best condition in recent history, supporting a favorable outlook for enhanced FCF conversion.

Bears say

Diebold Nixdorf Inc faces significant challenges that present a negative outlook for its stock, primarily due to vulnerability to tariff-related costs and a volatile trade environment, which could adversely impact financial forecasts. Additionally, the company is experiencing disruptions in its supply chain and logistical operations, compounded by lower than anticipated upgrade and replacement activities in its Banking vertical, leading to potential revenue volatility. Furthermore, currency fluctuations and liquidity concerns, characterized by a low average daily trading volume, may further contribute to negative sentiment surrounding the company's financial stability.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.